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Abstract
OBJECTIVE: Symptom patterns are an important
diagnostic concept in terms of Traditional Chinese
Medicine. Although symptom patterns and health
related quality of life (HRQOL) are common diag-
nostic measures for cancer patients, the association
between them has not been studied. This study
aimed to describe the changes in the pattern of
symptoms of Yang-deficiency, Yin-deficiency, blood
stasis, and HRQOL before and after chemotherapy,
and to examine the association between the pat-
terns and the cancer patients' HRQOL.
METHODS: A panel study was undertaken with
123 cancer patients who were about to begin their
first course of chemotherapy at four teaching hospi-
tals in Taiwan. A structured questionnaire was used
before and after chemotherapy. HRQOL was as-
sessed using the Medical Outcomes Survey
Short-Form 36. The Traditional Chinese Medical
Constitutional Scale was used to measure Yang-de-
ficiency, Yin-deficiency, and blood stasis patterns,
with higher scores indicating a larger deficiency.
RESULTS: The patients had significantly worse
scores for Yang-deficient pattern, Yin-deficiency pat-
tern, blood stasis pattern, and the physical compo-
nents of HRQOL after chemotherapy compared
with before chemotherapy. The HRQOL scores cor-
related significantly with Yang-deficiency, Yin-defi-
ciency, and the blood stasis pattern scores. A gener-
alized estimating equation model showed that the
HRQOL scores were significantly worse after che-
motherapy compared with before chemotherapy
for the physical component, but not for the mental
component. Blood stasis pattern was significantly
associated with a decreased HRQOL in both the
physical and mental components. A hemoglobin
level < 12 g/dL was associated with a worse physi-
cal component of HRQOL.
CONCLUSION: The Yang-deficiency, Yin-deficiency,
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and blood stasis patterns were all associated with
lowerHRQOLincancerpatientsafterchemotherapy.
© 2016 JTCM. All rights reserved.
Key words: Quality of life; Symptom pattern;
Drug therapy; Neoplasms; Medicine, Chinese tra-
ditional
INTRODUCTION
A symptom pattern is defined, in terms of Traditional
Chinese Medicine (TCM), as a group of symptoms
due to a medical condition, whereby the condition is
diagnosed and treated.1,2 It is believed that TCM symp-
tom patterns reflect meaningful differences in patients
with the same disease,3 and the symptom patterns may
change dynamically during the course of a disease.3,4
Researchers have reported that blood-stasis pattern and
deficiency patterns are common in patients with can-
cer.1,5 Blood-stasis pattern refers to a group of symp-
toms that are typically related to stasis or retention in
the blood and deficiency pattern refers to a group of
symptoms that are closely associated with deficiency in
energy (Qi) and body fluid.6,7 According to TCM theo-
ry, Qi, blood, and body fluid are the basic elements
which maintain the body's normal function.8 Both
blood stasis and deficiency patterns can be used to de-
termine an imbalance and abnormal function of the
viscera in the human body.6,7
Deficiency patterns can further be classified into
Yang-deficiency and Yin-deficiency. The former refers
to insufficiency in energy; the latter refers to insuffi-
ciency in blood and interstitial fluids.9,10 Blood stasis de-
ficiency pattern refers to the obstruction of blood and
Qi in the lesion site.6,7 Deficiency pattern and blood sta-
sis pattern have been used to characterize medical con-
ditions, and commonly, the condition of patients with
cancer.6-8
Studies have reported that chemotherapy is associated
with worse physical and mental quality of life for can-
cer patients.11-13 Many cancer patients receiving chemo-
therapy also use TCM in Taiwan.14 Treatment with
TCM can effectively manage chemotherapy-related
complications.15 Although health-related quality of life
(HRQOL) is a vital indicator in evaluating medical
treatment, few studies have examined the association
between TCM symptom patterns and the HRQOL of
cancer patients. In addition, no study has followed
these two health outcomes for cancer patients after
they have received chemotherapy.
The objective of this study was to describe the changes
in the patterns of Yang-deficiency, Yin-deficiency,
blood stasis, and HRQOL in cancer patients before
and after their first course of chemotherapy, and to ex-
amine the association between the TCM symptom pat-
terns and HRQOL.
MATERIALS ANDMETHODS
A panel study was used which included patients with
lung, liver, colorectal, and breast cancer who were
about to begin their first course of chemotherapy and
agreed to participate in the study at four hospitals in
northern Taiwan. A total of 149 eligible patients were
invited and 123 (82.6%) agreed to participate. Patients
were interviewed 3 days before chemotherapy and two
weeks after the start of chemotherapy. Data was collect-
ed from January 2009 to March 2011. The study was
approved by an institutional review board at the Taipei
Medical University Hospital (TMUH-05-08-10).
Measurements
The study variables included patient characteristics
(age, gender, marital status, education level, employ-
ment status, and religion), clinical characteristics (can-
cer diagnosis, cancer metastasis, and biochemical exam-
ination including: white blood cell, red blood cell, he-
moglobin, hematocrit, and platelet levels), Yang-defi-
ciency, Yin-deficiency, and blood stasis patterns, and
HRQOL. Patient and clinical characteristics were col-
lected three days before chemotherapy. Yang-deficiency,
Yin-deficiency, and blood stasis pattern, and HRQOL
were collected 3 days before and 2 weeks after chemo-
therapy.
The Traditional Chinese Medical Constitutional Scale
(TCMCS) was used to measure symptom patterns.9,10
The TCMCS included 44 items covering three symp-
tom pattern classifications: Yang-deficiency (19 items),
Yin-deficiency (19 items), and blood stasis (17 items).
Each item was rated on a 5-point Likert scale, ranging
from 0 to 4. Higher scores indicated a larger deficiency.
The Cronbach's α values were 0.83, 0.80, and 0.78 for
Yang-deficiency, Yin-deficiency, and blood stasis pat-
terns, respectively.
HRQOL was measured by the Medical Outcomes Sur-
vey Short-Form 36 (SF-36).16,17 The SF-36 instrument
composed 36 items covering eight domains: physical
functioning, role limitations from physical health prob-
lems, role limitations from emotional problems, body
pain, energy/fatigue, general health perceptions, social
functioning, and emotional well-being. Summary phys-
ical component scores (PCS) measured the physical as-
pects of quality of life, and mental component scores
(MCS) measured the mental aspects of quality of life.
The standardized scale ranged from 0 to 100. A higher
score indicated a better HRQOL. The reliability and
validity of the SF-36, Taiwanese version, has been
well-established.17-20
Statistical analysis
Statistical analysis was performed using SPSS for Win-
dows Statistics version 19.0 (IBM Corp., Armonk, NY,
USA). Descriptive analysis was performed using per-
centages, means ( xˉ ), and standard deviations (s). A
paired t-test was used to examine the changes in the
symptom patterns and HRQOL in cancer patients be-
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fore and after chemotherapy. The Pearson's correlation
coefficient was used to investigate the correlation be-
tween the symptom patterns and HRQOL. Multivari-
ate analysis was performed using generalized estimating
equations (GEE) to examine factors associated with
HRQOL (PCS and MCS). For all analyses, P < 0.05
was considered statistically significant.
RESULTS
The characteristics of the study participants are given
in Table 1. More than 60% of the 123 cancer patients
had breast cancer, approximately 20% had colorectal
cancer, approximately 10% had lung cancer, and 7%
had liver cancer. More than 60% had metastasis. Three
quarters of the study participants were women. The
mean age of the study participants was 53.6 years (s =
11.4; range 26-77). Blood test results showed 38.1% of
patients had low hemoglobin levels and 52.5% had a
low level of hematocrit.
The study patients had significantly higher mean
scores for Yang-deficiency, Yin-deficiency, and blood
stasis patterns after chemotherapy than before chemo-
therapy. The physical component scores for HRQOL
decreased significantly after chemotherapy compared
with before chemotherapy. There was no significant
difference in the MCS before and after chemotherapy
(Table 2).
All three symptom patterns of Yang-deficiency, Yin-de-
ficiency, and blood stasis were significantly and nega-
tively correlated with the physical and mental compo-
nents of HRQOL both before and after chemotherapy
(Table 3). The correlation between HRQOL and
Yang-deficiency ranged from－0.31 to－0.49, Yin-defi-
ciency －0.14 to －0.43, and blood stasis －0.35 to
－0.53.
Univariate analysis showed that hemoglobin levels and
hematocrit were significantly associated with PCS and
therefore they were included in the multivariate analy-
sis. Other variables (Table 1) that were not significantly
associated with PCS in the univariate analysis were not
included in the multivariate analysis. The hematocrit
lost its significance in the model and was excluded
from the multivariate model. The final model showed
that the PCS were significantly decreased after chemo-
therapy when compared with the PCS for the patients
before chemotherapy (β = －1.76, 95% CI: －3.44 to
－0.08; Table 4). A hemoglobin level < 12.0 g/dL was
significantly associated with worse a PCS (β = －4.05,
95% CI: －6.06 to －2.04). A higher blood stasis pat-
tern score was significantly associated with a lower
PCS (β = －0.60, 95% CI: －0.73 to －0.46). After
blood stasis pattern was entered into the model,
Yang-deficiency and Yin-deficiency lost their signifi-
cance and were removed from the model.
Univariate analysis showed that age was significantly as-
sociated with the MCS and therefore it was included
in the multivariate analysis. Other variables (Table 1)
that were not significantly associated with MCS in uni-
variate analysis were not included in the multivariate
analysis. Age lost its significance in the model and was
excluded from the multivariate model. The final model
showed MCS did not differ before and after chemo-
therapy (β = 0.95, P = 0.35; Table 4). A higher blood
stasis pattern score was significantly associated with a
lower MCS (β = －0.65, 95% CI: －0.81 to －0.49).
After blood stasis pattern was entered into the model,
Yang-deficiency and Yin-deficiency lost their signifi-
cance and were removed from the model.
DISCUSSION
The study finding showed that Yang-deficiency and
Table 1 Characteristics of the study participants (n = 123)
Variables
Sex
Marital status
Education level
Employment
status
Religion
Cancer
diagnosis
Cancer
metastasis
aWhite blood
cells (103/µL)
aRed blood cells
(106/µL)
bHemoglobin
(g/dL)
bHematocrit
(%)
Males
Females
Single
Married
Widowed
Divorced
Elementary school or lower
Junior high school
Senior high school
University or higher
Unemployed
Employed
None
Yes
Lung cancer
Colorectal cancer
Liver cancer
Brest cancer
None
Yes
4.0-11.0
<4.0≥11.0
4.2-6.1
＜4.2
12.0-18.0
<12.0
37.0-52.0
<37.0
n
31
92
25
82
10
6
30
10
38
45
54
69
22
101
12
25
9
77
46
77
100
8
11
60
59
73
45
56
62
%
25.2
74.8
20.3
66.7
8.1
4.9
24.4
8.1
30.9
36.6
43.9
56.1
17.9
82.1
9.8
20.3
7.3
62.6
37.4
62.6
84.0
6.7
9.2
50.4
49.6
61.9
38.1
47.5
52.5
Notes: afour patients had missing data for white and red blood
cells; bfive patients had missing data for hemoglobin and hemato-
crit levels.
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Yin-deficiency, blood stasis, and the physical aspects of
quality of life were significantly worse after chemother-
apy for the cancer patients when compared with their
patterns and quality before chemotherapy. This finding
was consistent with findings from previous studies of
patients with breast cancer.21,22 The lack of a significant
difference in the mental aspects of quality of life before
and after chemotherapy could be due to the short fol-
low-up period in the current study (only 2 weeks). As
the duration of chemotherapy is increased, the quality
of life is known to worsen for cancer patients.23,24 Fur-
ther study with a longer follow up is needed to further
examine the mental aspects of patient quality of life.
Nonetheless, our results suggest that chemotherapy
negatively affects deficiency and blood stasis pattern, as
well as the physical aspects of quality of life. Tradition-
al Chinese Medicine doctors should focus their treat-
ment on dealing with greater deficiency and blood sta-
sis during chemotherapy to support their patients com-
pleting multiple courses of chemotherapy.
We found that Yang-deficiency and Yin-deficiency, and
blood stasis were significantly and modestly correlated
with the physical and mental aspects of quality of life
for cancer patients. Health related quality of life has
been widely used as a subjective patient outcome of
cancer patients.25-27 Symptom patterns are used in
TCM as a guide for treatment, but it has not been
used widely as a patient outcome.4,28 The significant as-
sociation between symptom patterns and HRQOL sup-
ports the use of deficiency and blood stasis patterns as
patient outcomes in TCM treatment for cancer pa-
tients receiving chemotherapy. TCM doctors could fo-
cus their treatment on dealing with expected deteriorat-
ing Yang-deficiency and Yin-deficiency, and blood sta-
sis in patients receiving chemotherapy, which could in
turn improve HRQOL for those patients.
When Yang-deficiency, Yin-deficiency, and blood stasis
were considered together, only blood stasis was signifi-
cantly associated with HRQOL in cancer patients re-
ceiving chemotherapy in the multivariate model. In-
creased blood stasis was associated with worse physical
and mental aspects of quality of life. Thus special em-
phasis on blood stasis treatment could be helpful in im-
proving HRQOL in cancer patients receiving chemo-
Table 2 Comparison of Medical Outcomes Survey Short-Form 36 and symptom pattern scores before and after chemotherapy
Item
Medical outcomes survey short-form 36
Symptom pattern
Physical component score
Mental component score
Yang-deficiency
Yin-deficiency
Blood stasis
Before chemotherapy
xˉ
45
36
29
26
25
s
10
11
7
5
6
After chemotherapy
xˉ
41
36
31
29
27
s
9
11
8
6
7
P value
0.01a
0.10
0.01a
0.01a
0.02b
Note: P value from paired t-test, aP < 0.01; bP < 0.05.
Table 3 Correlation between symptom patterns and HRQOL
Item
Yang-deficiency pattern
Yin-deficiency pattern
Blood stasis pattern
Physical component of
quality of life before
chemotherapy
－0.49a
－0.28a
－0.53a
Physical component of
quality of life after
chemotherapy
－0.35a
－0.14a
－0.42a
Mental com- ponent of
quality of life before
chemotherapy
－0.31a
－0.26a
－0.35a
Mental component of
quality of life after
chemotherapy
－0.49a
－0.43a
－0.53a
Note: HRQOL: health related quality of life, aP < 0.01.
Item
PCS
MCS
Variable
Intercept
After chemotherapy
Hemoglobin < 12.0 g/dL
Blood stasis pattern
Intercept
After chemotherapy
Blood stasis pattern
β
61.16
－1.76
－4.05
－0.60
52.25
0.95
－0.65
Standard error
1.89
0.86
1.03
0.07
2.34
1.01
0.01
95% CI
(57.45, 64.87)
(－3.44,－0.08)
(－6.06,－2.04)
(－0.73,－0.46)
(47.65, 58.98)
(－1.04, 2.94)
(－0.81,－0.49)
P value
<0.01a
0.04b
<0.01a
<0.01a
<0.01a
0.35
<0.01a
Table 4 Generalized estimating equation models for the PCS and MCS of quality of life
Notes: PCS: physical component score; MCS: mental component score. The references are before chemotherapy and hemoglobin ≥
12 g/dL. aP < 0.01; bP < 0.05.
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therapy. Further study is needed to examine this hy-
pothesis.
Low hemoglobin levels were also associated with lower
physical quality of life. Low hemoglobin levels may in-
crease feelings of fatigue,29,30 and hence, can impact the
physical aspects of quality of life. Low hemoglobin lev-
els were independent of blood stasis pattern. Clinical
management of low hemoglobin levels is recommend-
ed in order to improve the physical aspects of quality
of life for cancer patients. For example, the use of
TCM therapies, such as Shiquandabu Tang, has been
associated with increased hemoglobin levels among pa-
tients with cancer.31
Yang- and Yin-deficiency, blood stasis, and the physical
aspects of quality of life for cancer patients were nega-
tively affected by chemotherapy. Yang-deficiency,
Yin-deficiency, and blood stasis patterns were associat-
ed with both the physical and mental aspects of quality
of life for cancer patients. Based on these results TCM
doctors could provide treatment to prevent the symp-
toms from worsening in the patterns of Yang-deficien-
cy, Yin-deficiency, and blood stasis for cancer patients
receiving chemotherapy, with special emphasis on
blood stasis, which could help improve their HRQOL.
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